← BWX overview

BWX vs Parsons: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

BWX Technologies Inc (BWXT)

Q3 2026
▲4

BWXT Q3: Guidance Raised, Backlog Surges, New Nuclear Deals

  • Guidance raised after strong Q2 results BWXT raised its full-year guidance after Q2 revenue rose 18% to $901.6 million and earnings per share beat estimates. This shows the company is performing better than expected and expects continued strength.

    Guidance raise and earnings beat are key new positive developments that directly affect investor expectations.

  • Backlog jumps 39.6% to $8.4 billion BWXT's backlog surged 39.6% to $8.4 billion, indicating strong future revenue visibility. This growth reflects robust demand across its nuclear defense and commercial businesses.

    Backlog growth is a critical indicator of future revenue and was not mentioned in earlier reports.

  • New contracts: Army microreactor and Canadian nuclear plant BWXT won a U.S. Army contract for the Janus microreactor and a deal for a Canadian transportable nuclear plant. These expand its footprint in mobile and small nuclear power.

    These are new contract wins that open additional revenue streams and demonstrate BWXT's technological leadership.

  • First investment-grade rating and strategic portfolio moves BWXT secured its first investment-grade credit rating (BBB) and sold its medical unit for $800 million, sharpening focus on core nuclear operations. The Saudi 30-year nuclear pact also boosts long-term prospects.

    These strategic actions improve financial flexibility and focus, supporting growth and shareholder value.

September 2026
▲4

BWXT Wins New Reactor Deals, Expands Capacity, Targets $6B Revenue by 2030

  • U.S. Army Janus Program Selection BWXT was chosen to deploy its BANR microreactor for the U.S. Army's Janus program, with the first unit planned at Fort Campbell. This is a major government contract that adds long-term revenue and validates BWXT's advanced reactor technology, pushing the stock up.

    This is a new, significant contract win that directly boosts future demand and revenue visibility.

  • Manufacturing Expansion and Strong 2025 Revenue BWXT expanded its Cambridge, Ontario facility and is investing in uranium processing and advanced manufacturing. Its 2025 revenue rose 18.3% to $3.2 billion, with projected EPS growth ahead. This shows execution and capacity to meet rising nuclear demand, supporting the stock.

    It highlights tangible growth and investment that underpin future earnings.

  • Inaugural Investment Grade Credit Rating Fitch gave BWXT its first investment grade rating of BBB with a stable outlook, citing its strong market position and cash flow. This lowers borrowing costs and signals financial health, which can attract more investors and lift the stock.

    A new credit rating improves BWXT's financial profile and investor appeal.

  • Investor Day Targets and Canadian Microreactor Deal BWXT set 2030 revenue targets of $5.5–$6 billion, doubled its backlog to $8.4 billion, and is selling a non-core unit to fund nuclear growth. It also won a Canadian transportable nuclear plant project. These moves clarify long-term growth and add new demand, supporting the stock despite a recent pullback.

    These are new strategic updates that directly address future growth and market opportunities.

Latest
▲4

BWXT Wins New Reactor Deals, Expands Capacity, Targets $6B Revenue by 2030

  • U.S. Army Janus Program Selection BWXT was chosen to deploy its BANR microreactor for the U.S. Army's Janus program, with the first unit planned at Fort Campbell. This is a major government contract that adds long-term revenue and validates BWXT's advanced reactor technology, pushing the stock up.

    This is a new, significant contract win that directly boosts future demand and revenue visibility.

  • Manufacturing Expansion and Strong 2025 Revenue BWXT expanded its Cambridge, Ontario facility and is investing in uranium processing and advanced manufacturing. Its 2025 revenue rose 18.3% to $3.2 billion, with projected EPS growth ahead. This shows execution and capacity to meet rising nuclear demand, supporting the stock.

    It highlights tangible growth and investment that underpin future earnings.

  • Inaugural Investment Grade Credit Rating Fitch gave BWXT its first investment grade rating of BBB with a stable outlook, citing its strong market position and cash flow. This lowers borrowing costs and signals financial health, which can attract more investors and lift the stock.

    A new credit rating improves BWXT's financial profile and investor appeal.

  • Investor Day Targets and Canadian Microreactor Deal BWXT set 2030 revenue targets of $5.5–$6 billion, doubled its backlog to $8.4 billion, and is selling a non-core unit to fund nuclear growth. It also won a Canadian transportable nuclear plant project. These moves clarify long-term growth and add new demand, supporting the stock despite a recent pullback.

    These are new strategic updates that directly address future growth and market opportunities.

August 2026
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

Q2 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

June 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

Parsons Corp (PSN)

Q3 2026
▲2▼2

Parsons Plunges on Guidance Cut and Surprise Loss

  • Guidance Slashed and Surprise Q2 Loss Parsons cut its full-year guidance and reported an unexpected Q2 net loss, with revenue of $1.58 billion missing expectations by 1.9%. This triggered a 38% stock plunge and a 25.5% drop to $46.19.

    This is the main negative event that drove the stock down sharply during the period.

  • Securities Investigations Launched Multiple law firms launched investigations into whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or reputational damage, weighing on the stock.

    This is a new negative development that adds to investor concerns and could affect the stock price.

  • New Contract Wins Provide Some Support Parsons secured several contracts: Army cybersecurity work, a $169.5M Army contract, a five-year Knoxville airport terminal project, and an $85M Space Command advisor role. These wins show ongoing demand for its services.

    These new contracts are positive developments that could help offset the negative financial news.

  • Gordie Howe Bridge Opens and Insider Buying The $4.7 billion Gordie Howe Bridge opened with Parsons as owner's engineer, highlighting its major project capabilities. Director George Ball bought 20,000 shares, signaling insider confidence.

    These events show project execution and insider belief, which may support the stock despite other negatives.

August 2026
▲3▼1

Parsons wins new contracts but weak Q2 guidance and revenue miss weigh on shares

  • Weak Q2 results and lowered guidance Parsons reported flat Q2 revenue of $1.58 billion, 1.9% below expectations, and full-year revenue and EBITDA guidance that missed significantly, sending the stock down 25.5% to $46.19. This is the main reason the stock has been weak, as it shows the company's growth is stalling and future profits may be lower than expected.

    This is the biggest negative force on PSN's price this period, directly explaining the sharp drop.

  • New contract wins add to backlog Parsons won a five-year terminal development contract at Knoxville's McGhee Tyson Airport and an $85 million Owner's Advisor agreement for U.S. Space Command headquarters. These awards bring in new work and support future revenue, which is a positive for the stock even as current results disappoint.

    These are new, concrete contract wins that show demand for Parsons' services and support the bull case.

  • Insider buying signals confidence Director George Ball bought 20,000 shares at $47.97, worth about $959,000, increasing his holdings by 13%. Insider buying is often seen as a sign that someone close to the company believes the stock is undervalued, which can support the share price.

    This is a new insider purchase that may boost investor confidence after the stock's decline.

  • Gordie Howe Bridge opens, showcasing Parsons' role The $4.7 billion Gordie Howe International Bridge opened, with Parsons as owner's engineer. While the project was already known, its completion highlights Parsons' expertise in large infrastructure projects and could help win similar work in the future.

    This event is new and positively reinforces Parsons' reputation, though its immediate financial impact is limited.

Latest
▲3▼1

Parsons wins new contracts but weak Q2 guidance and revenue miss weigh on shares

  • Weak Q2 results and lowered guidance Parsons reported flat Q2 revenue of $1.58 billion, 1.9% below expectations, and full-year revenue and EBITDA guidance that missed significantly, sending the stock down 25.5% to $46.19. This is the main reason the stock has been weak, as it shows the company's growth is stalling and future profits may be lower than expected.

    This is the biggest negative force on PSN's price this period, directly explaining the sharp drop.

  • New contract wins add to backlog Parsons won a five-year terminal development contract at Knoxville's McGhee Tyson Airport and an $85 million Owner's Advisor agreement for U.S. Space Command headquarters. These awards bring in new work and support future revenue, which is a positive for the stock even as current results disappoint.

    These are new, concrete contract wins that show demand for Parsons' services and support the bull case.

  • Insider buying signals confidence Director George Ball bought 20,000 shares at $47.97, worth about $959,000, increasing his holdings by 13%. Insider buying is often seen as a sign that someone close to the company believes the stock is undervalued, which can support the share price.

    This is a new insider purchase that may boost investor confidence after the stock's decline.

  • Gordie Howe Bridge opens, showcasing Parsons' role The $4.7 billion Gordie Howe International Bridge opened, with Parsons as owner's engineer. While the project was already known, its completion highlights Parsons' expertise in large infrastructure projects and could help win similar work in the future.

    This event is new and positively reinforces Parsons' reputation, though its immediate financial impact is limited.

July 2026
▲2▼2

Parsons Slashes 2026 Guidance, Triggers 38% Plunge and Investigations

  • 2026 Guidance Cut and Q2 Miss Parsons cut full-year 2026 revenue and profit guidance and reported a surprise net loss, sending shares down 38%. The company blamed divestitures and delayed awards, but investors fear weaker future earnings.

    This is the main new event that directly caused the stock to plummet and changes the earnings outlook.

  • Securities Investigations Launched Multiple law firms are investigating whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or lawsuits, further pressuring the stock.

    New investigations are a direct consequence of the guidance cut and add a new risk factor for investors.

  • New Army Cyber Contract Parsons won a contract to provide cybersecurity for the U.S. Army Research Lab, deepening its role in high-value defense tech. This supports long-term revenue but is overshadowed by the guidance cut.

    This is a new positive development that shows underlying demand, but its impact is muted by the larger negative news.

  • Industrial Modernization Demand Parsons highlighted a $169.5M Army contract and growing demand for industrial base modernization. This shows a healthy pipeline, but near-term execution issues and guidance cut dominate investor sentiment.

    This new contract and demand signal are positive but not enough to offset the negative guidance revision.

▲2▼2

Parsons Slashes 2026 Guidance, Triggers 38% Plunge and Investigations

  • 2026 Guidance Cut and Q2 Miss Parsons cut full-year 2026 revenue and profit guidance and reported a surprise net loss, sending shares down 38%. The company blamed divestitures and delayed awards, but investors fear weaker future earnings.

    This is the main new event that directly caused the stock to plummet and changes the earnings outlook.

  • Securities Investigations Launched Multiple law firms are investigating whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or lawsuits, further pressuring the stock.

    New investigations are a direct consequence of the guidance cut and add a new risk factor for investors.

  • New Army Cyber Contract Parsons won a contract to provide cybersecurity for the U.S. Army Research Lab, deepening its role in high-value defense tech. This supports long-term revenue but is overshadowed by the guidance cut.

    This is a new positive development that shows underlying demand, but its impact is muted by the larger negative news.

  • Industrial Modernization Demand Parsons highlighted a $169.5M Army contract and growing demand for industrial base modernization. This shows a healthy pipeline, but near-term execution issues and guidance cut dominate investor sentiment.

    This new contract and demand signal are positive but not enough to offset the negative guidance revision.

Q2 2026
▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.

June 2026
▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.

▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.